Orfidal and confusional state Patient Reports February 09, 2010

Orfidal Side Effects Report #4652521-4
Orfidal side effect was reported by a Health Professional from on Apr 15, 2005. Female patient, 60 years of age, was diagnosed with insomnia and was treated with Orfidal. After drug was administered, patient experienced the following side effects: agitation, confusional state, hallucination, nervousness. Orfidal dosage: 1 MG Q DAY PO. During the same period patient was treated with SEROQUEL. Patient recovered.

Orfidal Side Effects Report #5215201-2
Orfidal side effect was reported by a Health Professional from SPAIN on Dec 29, 2006. Female patient, 84 years of age, was diagnosed with depression  and was treated with Orfidal. After drug was administered, patient experienced the following side effects: aggression, agitation, confusional state, dry mouth, fall , nausea . Orfidal dosage: unknown. During the same period patient was treated with CYMBALTA. Patient recovered.

Orfidal Side Effects Report #5764751-9
Orfidal side effect was reported by a Health Professional from SPAIN on June 02, 2008. Female patient, 64 years of age, was diagnosed with disorientation, alcohol detoxification, bipolar disorder  and was treated with Orfidal. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, confusional state, hypernatraemia, metabolic acidosis, neuroleptic malignant syndrome, pyrexia. Orfidal dosage: unknown. During the same period patient was treated with HALOPERIDOL, LITHIUM CARBONATE, ANTABUSE, ETUMINA, VANDRAL RETARD, AKINETON. Patient was hospitalized. Patient recovered.

Orfidal Side Effects Report #5781848-8
Orfidal side effect was reported by a Health Professional from SPAIN on June 02, 2008. Female patient, 64 years of age, was diagnosed with alcohol detoxification, bipolar disorder , disorientation and was treated with Orfidal. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood osmolarity abnormal, confusional state, disorientation, expressive language disorder, hypernatraemia, metabolic acidosis, neuroleptic malignant syndrome, pyrexia. Orfidal dosage: (1 MG QD ORAL, (1 MG QD ORAL). During the same period patient was treated with AKINETON, LITHIUM CARBONATE, ANTABUSE, ETUMINA, HALOPERIDOL. Patient was hospitalized. Patient recovered.